Maryland earns a B, ranking 18th out of 51 states. Six million people live here, and by most measures they're doing reasonably well: they smoke less than the average American, get screened for cancer more often, and carry insurance at higher rates. The state's death rate of 8,650 per 100,000 sits well below the national average of 10,368. With a median household income of $89,867, 6th in the country, Maryland has the resources to build a genuinely exceptional health system.
For some of its residents, it has. The contradiction at the center of Maryland's health story is this: the state ranks dead last in Medicare acceptance rate. Just 87% of its Medicare-enrolled providers will take new Medicare patients. That's worse than every other state, including Mississippi, which ranks last overall but manages a 95.9% acceptance rate. A state home to Johns Hopkins, the NIH campus in Bethesda, and the 6th highest incomes in the country has somehow built a healthcare system that fails its elderly and disabled patients more completely than anywhere else in America.
Then there's the geography. Drive from Howard County to Baltimore city and you cover maybe 30 miles. The death rates in those two places differ by a factor of 3.5. Maryland doesn't have a health problem. It has a distribution problem. And all the wealth and research infrastructure in the state hasn't touched it.
The ReportCard numbers tell a story that starts well and frays around the edges. Obesity sits at 36.4% of adults, just under the national 37.5%. That still means roughly 2.25 million Marylanders are managing the downstream consequences of metabolic illness. The prescription data confirms it: the top drug by claims is Atorvastatin Calcium, a cholesterol medication, followed by Amlodipine Besylate for blood pressure. These aren't coincidences. They're the pharmacological signature of a state dealing with what happens when obesity and inactivity compound each other year after year.
Smoking is a genuine bright spot. Just 12.7% of Maryland adults smoke, well below the national 16.1%. That gap likely suppresses rates of COPD, lung cancer, and heart disease that would otherwise burden the system. The uninsured rate of 8.5% is nearly three points better than the national 11.4%. For the roughly 525,000 Marylanders still without coverage, getting sick still means choosing between the ER and waiting. But coverage drives early diagnosis, and here Maryland does better than most.
Child poverty runs at 14.6%, well below the national 19.4%. That difference matters long after any clinic visit. Kids who grow up food-insecure develop stress responses that affect cardiovascular and immune health for decades. About 18.1% of adults rate their health as fair or poor, compared to 21.3% nationally. Nearly one in five people describing their own health as less than good isn't a success story. It's a baseline to work from.
The CDCDeviationsChart for Maryland reads like an above-average student's transcript: better across the board, sometimes significantly. The disability rate stands at 27.6% of adults, nearly six points below the national 33.5%. Higher incomes and better preventive care keep people functional longer. It shows up across a dozen measures.
Screening is where Maryland most clearly separates from the national average. Mammography use reaches 79.3% among eligible women, more than five points above the national figure. Colorectal cancer screening covers 65.1% of eligible adults versus 60.7% nationally. Add cholesterol screening at 88.3% against a national 84.2%, and a consistent picture emerges: Marylanders are catching problems earlier. Catching a cancer early versus late isn't just a statistical difference. It's often the difference between treatment and survival.
Dental health tells the same story. Nearly two-thirds of Maryland adults visited a dentist in the past year, more than five points above the national average, and only 11% of residents 65 and older have lost all their teeth, compared to 16% nationally. Tooth loss is a lifetime measure of healthcare access. Maryland's numbers suggest generations of better-than-average engagement with the medical system. Depression rates come in at 21.4%, about two points below the national 23.5%. The state has more than 12,000 clinical social workers and 9,000 mental health counselors. Whether that workforce is reaching the people who need it most is a different question entirely.
The SocialRadarChart for Maryland shows a state that performs better than average on most social determinants but hasn't escaped them. About 14.9% of adults experienced food insecurity in the past 12 months. Better than the national 16.8%, yes. But it still represents nearly a million people who weren't consistently sure about their next meal. Severe housing cost burden sits at 13.1% of residents, virtually identical to the national 13.2%. Maryland's high average incomes don't insulate everyone from one of the most expensive housing markets on the East Coast.
The geography tells three different stories. The DC suburbs price out working-class families who depend on the service economy but can't afford the rents. Baltimore city carries decades of disinvestment that statewide income averages can't mask. The rural Eastern Shore faces something different: thin services, an economy that never recovered from the decline of agriculture and seafood, and a healthcare infrastructure that was sparse to begin with.
Child poverty at 14.6% shapes everything downstream. Maryland has the resources to address these upstream causes. The question is whether those resources reach the places where the need is concentrated. Income inequality scores 4.4 on standard measures, a number that reflects something visible from the highway: immense wealth and persistent poverty separated by short drives and invisible boundaries.
Maryland has 114,870 healthcare providers registered across 111 specialties. The composition of that workforce is revealing. Clinical social workers lead all specialties at 12,876, followed by nurse practitioners at 11,265 and mental health counselors at 9,229. Internal medicine physicians total 4,785. The state's orientation is toward behavioral health first, primary care second. The physical infrastructure includes 56 hospitals, 221 nursing homes, 167 dialysis centers, and 52 home health agencies serving 6.18 million residents.
Telehealth is a genuine strength. Maryland ranks 3rd nationally, with 22.1% of CMS-enrolled providers offering virtual care, compared to just 6.9% in Mississippi. That ranking reflects both the state's technology-forward economy and a deliberate post-pandemic expansion. But telehealth has limits. It doesn't reach elderly patients without reliable broadband. It doesn't replace hands-on diagnostics. And it doesn't fix the mismatch between where providers practice and where patients live.
Nearly 115,000 providers are registered in Maryland. So why are 2.4 million residents living in primary care shortage areas? The state has 67 such areas, plus 52 dental shortage areas affecting 2.3 million people and 41 mental health shortage areas covering another 2.15 million. Together, they affect roughly a third of the state's population. Providers concentrated in Montgomery County and Howard County and the Baltimore suburbs can't solve access problems in Dorchester or Allegany. The numbers and the map tell different stories.
Maryland residents use emergency rooms at a rate of 616.9 visits per 1,000 people annually. High ER utilization is almost always a symptom of failures earlier in the care chain: people without a regular doctor, people who couldn't get a timely appointment, people whose condition worsened because they waited. With 2.4 million residents in primary care shortage areas, some of that volume is structurally inevitable. The emergency room becomes the only door that's open.
With 221 nursing homes and 52 home health agencies statewide, the capacity for post-discharge support exists. Whether it reaches patients consistently, particularly those in shortage areas, is a different matter. Readmission data at this level of aggregation doesn't capture that nuance. The ER volume does.
Maryland's median household income of $89,867 sits well above the national median of $65,754, and the uninsured rate is nearly three points better than the national average. On paper, Marylanders are better positioned than most to afford care. In practice, those averages dissolve at the county level. In Allegany County, median income is $54,759. In Baltimore city, it's $58,616. People in those places face the same healthcare costs against a financial backdrop that looks nothing like the state headline.
The prescription profile maps directly onto the disease burden. Atorvastatin Calcium leads with 2.15 million claims for cholesterol. Amlodipine Besylate and Lisinopril follow for blood pressure. But the most revealing number in Maryland's drug data isn't a cholesterol pill. It's Apixaban, a blood thinner used to prevent stroke and clots, generating 618,000 claims at a cost of $603 million alone. That's more than many states spend on their entire prescription program.
Total Medicare prescription spending runs to $6.3 billion across 36.7 million claims. The insurer landscape reflects a competitive market: Aetna covers the most providers at 48,018, followed by CareFirst BCBS at 46,360 and Cigna at 40,873. Medicare enrolls 37,777 providers, a meaningful network, but one that sits below three commercial carriers. CareFirst near the top reflects its historically dominant position in Maryland's small employer and individual markets.
Pharmaceutical companies made 275,696 payments totaling $45.1 million to 21,028 Maryland providers across 809 companies. The average individual payment was $163. That figure doesn't tell you much. The breakdown does.
Consulting fees led at $10.9 million. Speaker and faculty compensation added $10.5 million. Royalty and licensing arrangements generated $9.5 million from just 258 payments, meaning a small group of researchers is producing intellectual property that generates significant industry revenue. At the other end of the spectrum, food and beverage payments account for 252,800 individual transactions totaling $7.4 million. That's the lunch-and-learn economy at scale, playing out in break rooms and conference halls across the state every week.
More than 21,000 providers receiving industry money in a single reporting period is a substantial share of Maryland's active clinical workforce. These relationships aren't inherently corrupting. Many reflect legitimate research and education collaborations anchored in the state's academic medicine ecosystem. But the scope of pharmaceutical industry engagement here, from NIH-adjacent research campuses in Bethesda to community practices on the Eastern Shore, means industry relationships touch clinical practice at every level. What gets prescribed, what gets emphasized in continuing education, and what research gets funded all carry traces of those payment relationships.
Maryland has 72 providers actively excluded from Medicare and Medicaid programs, a rate of 0.6 per 1,000 providers, ranking worse than about a third of states. Exclusions happen for fraud, patient harm, license revocation, and felony convictions. Seventy-two active exclusions in a state this size isn't alarming in isolation. In a region with this concentration of federal healthcare spending, it's a number worth watching.
The Medicare opt-out data is harder to rationalize. Maryland has 1,839 providers who've formally opted out of Medicare, a rate of 16.0 per 1,000 providers, ranking worse than all but three states. West Virginia, which ranks 47th overall on health outcomes, has a Medicare opt-out rate of just 2.8 per 1,000. And only 87% of Medicare-enrolled providers accept new Medicare patients, the worst acceptance rate in the country. Mississippi manages 95.9%.
In practical terms, Maryland's Medicare beneficiaries face more barriers to finding a willing provider than patients in any other state. In a state with the 6th highest median income and the 3rd highest NIH funding per capita, that isn't a resource problem. It's a choice. Thousands of individual choices that compound into a system.
Maryland's research infrastructure is exceptional in ways few states can match. The state hosts 23,571 active clinical trials, ranking 10th nationally. NIH funding reaches $273 million across 441 grants. Per capita, that's $44 per Maryland resident, ranking 3rd nationally. Idaho, which ranks 15th overall on health outcomes, receives about $1 per capita in NIH funding. The gap between those two states isn't just a number. It's the difference between being a center of biomedical knowledge and consuming it from the outside.
The concentration of federal health agencies and research institutions in the Baltimore-Washington corridor drives these figures. The NIH campus sits in Bethesda. Johns Hopkins anchors Baltimore. The University of Maryland medical system extends the research capacity further. Maryland doesn't just treat disease. It tries to understand and prevent it at a fundamental level.
But do the discoveries emerging from those institutions translate into better care for the Marylanders who need them most? The 2.4 million people in primary care shortage areas aren't likely to benefit directly from the next NIH-funded clinical trial. Research and access are different functions, and Maryland has invested heavily in one while leaving the other with gaps large enough to affect a third of the state.
No number in Maryland's health profile reveals more than the gap between its healthiest and most struggling counties. The county dot plot doesn't cluster. It stretches.
Howard County posts a death rate of 4,573 per 100,000 with a median household income of $140,113 and an obesity rate of 30%. Montgomery County sits at 4,785 with income averaging $125,076. These are among the healthiest and wealthiest counties in America. Howard County's death rate approaches San Juan County in Washington, the nation's single healthiest county at 3,315 per 100,000.
Then there's Baltimore city. Death rate: 15,998 per 100,000. Median income: $58,616. Obesity at 40%. People in Baltimore city die at rates that rival communities in the nation's most deprived rural areas. The gap between Howard County and Baltimore city is a factor of 3.5, two places separated by about 30 miles of interstate highway and decades of divergent investment, policy, and economic fortune.
Dorchester County on the Eastern Shore records a death rate of 12,187. Allegany County in Western Maryland reaches 11,358. Washington County comes in at 10,710. These aren't outliers clustered at the margins of an otherwise healthy state. They're places where public health infrastructure has been chronically underfunded and the economy never recovered from industrial decline. Maryland's compact geography makes the divide visible in a way that larger states can obscure. You don't need to travel far to see both ends of the distribution. You just need to know where to look.
The central irony of Maryland's health story is that its greatest asset, its proximity to power, money, and some of the world's best medical research, has become a mechanism for stratification rather than a corrective to it. The NIH invests $273 million in the state. Johns Hopkins trains generations of physicians who, once credentialed, opt out of Medicare at the highest rate in the country. The telehealth platforms that lift Maryland to 3rd nationally in virtual care reach people who already have smartphones, reliable internet, and insurance. The research breakthroughs emerging from Bethesda and Baltimore get priced beyond reach for the roughly 525,000 Marylanders still uninsured, and for many more who are technically covered but practically underserved.
Maryland has built a genuinely outstanding health system for a portion of its population. The problem is that the portion it serves best tends to need the least help. Howard County and Montgomery County would score well by almost any health metric in the developed world. Baltimore city, within the same state, is dying at rates that rival communities with a fraction of Maryland's resources. That gap doesn't persist because no one knows it exists. It persists because the forces that would close it compete against the revealed preferences of providers who've calculated that their time is worth more than what Medicare pays.
A state that ranks 3rd in NIH funding per capita and last in Medicare acceptance has made a structural choice. Whether that choice was conscious or just the accumulated result of thousands of individual decisions by thousands of physicians, the outcome is the same. Maryland invests heavily in the future of medicine while some of its most vulnerable current patients can't find a willing doctor. That's not a health failure. It's a values statement, and the data makes it impossible to avoid reading it that way.